Home LiteratureArticle Details
PMID: 10357807 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S. Research Support, U.S. Gov't, P.H.S.

Functional glycan-free adhesion domain of human cell surface receptor CD58: design, production and NMR studies.

The EMBO journal ·Vol. 18 ·No. 11 ·1999-06-01 ·Pages 2941-9

Sun ZY, Dötsch V, Kim M, Li J, Reinherz EL, Wagner G

Abstract

A general strategy is presented here for producing glycan-free forms of glycoproteins without loss of function by employing apolar-to-polar mutations of surface residues in functionally irrelevant epitopes. The success of this structure-based approach was demonstrated through the expression in Escherichia coli of a soluble 11 kDa adhesion domain extracted from the heavily glycosylated 55 kDa human CD58 ectodomain. The solution structure was subsequently determined and binding to its counter-receptor CD2 studied by NMR. This mutant adhesion domain is functional as determined by several experimental methods, and the size of its binding site has been probed by chemical shift perturbations in NMR titration experiments. The new structural information supports a 'hand-shake' model of CD2-CD58 interaction involving the GFCC'C" faces of both CD2 and CD58 adhesion domains. The region responsible for binding specificity is most likely localized on the C, C' and C" strands and the C-C' and C'-C" loops on CD58.

MeSH Terms
Amino Acid Sequence Binding Sites CD2 Antigens/chemistry,metabolism CD58 Antigens/biosynthesis,chemistry,genetics,metabolism Escherichia coli/genetics Glycosylation Humans Models, Molecular Molecular Sequence Data Molecular Weight Mutation Nuclear Magnetic Resonance, Biomolecular Peptide Fragments/biosynthesis,chemistry,genetics,metabolism Polysaccharides/chemistry,genetics Protein Conformation Protein Engineering Protein Structure, Secondary Recombinant Proteins/biosynthesis,chemistry,metabolism Solubility
Chemicals
CD2 Antigens CD58 Antigens Peptide Fragments Polysaccharides Recombinant Proteins
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Sun Z Y
Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA.
Dötsch V
Kim M
Li J
Reinherz E L
Wagner G
References (53)
53 references, click to expand
  1. The CD58 (LFA-3) binding site is a localized and highly charged surface area on the AGFCC'C" face of the human CD2 adhesion domain.
    Proc Natl Acad Sci U S A. 1993 Dec 15;90(24):11613-7 PMID: 7505442
  2. Blockade of CD2-LFA-3 interactions protects human skin allografts in immunodeficient mouse/human chimeras.
    Nat Biotechnol. 1997 Aug;15(8):759-62 PMID: 9255790
  3. Function of adhesion molecules lymphocyte function-associated antigen-3 and intercellular adhesion molecule-1 on human epidermal Langerhans cells in antigen-specific T cell activation.
    J Immunol. 1994 Apr 1;152(7):3400-9 PMID: 7511646
  4. The mutant Escherichia coli F112W cyclophilin binds cyclosporin A in nearly identical conformation as human cyclophilin.
    Biochemistry. 1994 May 17;33(19):5711-20 PMID: 8180197
  5. The 13C chemical-shift index: a simple method for the identification of protein secondary structure using 13C chemical-shift data.
    J Biomol NMR. 1994 Mar;4(2):171-80 PMID: 8019132
  6. Human cell-adhesion molecule CD2 binds CD58 (LFA-3) with a very low affinity and an extremely fast dissociation rate but does not bind CD48 or CD59.
    Biochemistry. 1994 Aug 23;33(33):10149-60 PMID: 7520278
  7. Structure of the glycosylated adhesion domain of human T lymphocyte glycoprotein CD2.
    Structure. 1993 Sep 15;1(1):69-81 PMID: 7915183
  8. CD2 is involved in maintenance and reversal of human alloantigen-specific clonal anergy.
    J Exp Med. 1994 Nov 1;180(5):1665-73 PMID: 7525835
  9. Interaction between human CD2 and CD58 involves the major beta sheet surface of each of their respective adhesion domains.
    J Exp Med. 1994 Nov 1;180(5):1861-71 PMID: 7525842
  10. Costimulation by purified intercellular adhesion molecule 1 and lymphocyte function-associated antigen 3 induces distinct proliferation, cytokine and cell surface antigen profiles in human "naive" and "memory" CD4+ T cells.
    J Exp Med. 1994 Dec 1;180(6):2125-35 PMID: 7525848
  11. Structure and mobility of the PUT3 dimer.
    Nat Struct Biol. 1997 Sep;4(9):744-50 PMID: 9303003
  12. Torsion angle dynamics for NMR structure calculation with the new program DYANA.
    J Mol Biol. 1997 Oct 17;273(1):283-98 PMID: 9367762
  13. Modulation of the CD2 receptor and not disruption of the CD2/CD48 interaction is the principal action of CD2-mediated immunosuppression in the rat.
    Cell Immunol. 1997 Nov 25;182(1):57-67 PMID: 9427810
  14. Gene structure, promoter characterization, and basis for alternative mRNA splicing of the human CD58 gene.
    J Immunol. 1998 Mar 15;160(6):2862-71 PMID: 9510189
  15. Structure of translation factor eIF4E bound to m7GDP and interaction with 4E-binding protein.
    Nat Struct Biol. 1997 Sep;4(9):717-24 PMID: 9302999
  16. CD2 and the nature of protein interactions mediating cell-cell recognition.
    Immunol Rev. 1998 Jun;163:217-36 PMID: 9700513
  17. An alternative pathway of T-cell activation: a functional role for the 50 kd T11 sheep erythrocyte receptor protein.
    Cell. 1984 Apr;36(4):897-906 PMID: 6231105
  18. Activation of cytolytic T lymphocyte and natural killer cell function through the T11 sheep erythrocyte binding protein.
    Nature. 1985 Oct 3-9;317(6036):428-30 PMID: 2864636
  19. Rosetting of activated human T lymphocytes with autologous erythrocytes. Definition of the receptor and ligand molecules as CD2 and lymphocyte function-associated antigen 3 (LFA-3).
    J Exp Med. 1987 Mar 1;165(3):664-76 PMID: 3102675
  20. Purified lymphocyte function-associated antigen 3 binds to CD2 and mediates T lymphocyte adhesion.
    J Exp Med. 1987 Mar 1;165(3):677-92 PMID: 3102676
  21. The T lymphocyte glycoprotein CD2 binds the cell surface ligand LFA-3.
    Nature. 1987 Mar 26-Apr 1;326(6111):400-3 PMID: 2951597
  22. The lymphocyte function-associated LFA-1, CD2, and LFA-3 molecules: cell adhesion receptors of the immune system.
    Annu Rev Immunol. 1987;5:223-52 PMID: 3109455
  23. Primary structure of lymphocyte function-associated antigen 3 (LFA-3). The ligand of the T lymphocyte CD2 glycoprotein.
    J Exp Med. 1987 Oct 1;166(4):923-32 PMID: 3309127
  24. An LFA-3 cDNA encodes a phospholipid-linked membrane protein homologous to its receptor CD2.
    Nature. 1987 Oct 29-Nov 4;329(6142):840-2 PMID: 3313052
  25. Monoclonal antibody and ligand binding sites of the T cell erythrocyte receptor (CD2).
    Nature. 1987 Oct 29-Nov 4;329(6142):842-6 PMID: 2444890
  26. Anchoring mechanisms for LFA-3 cell adhesion glycoprotein at membrane surface.
    Nature. 1987 Oct 29-Nov 4;329(6142):846-8 PMID: 3313053
  27. Structural and binding analysis of a two domain extracellular CD2 molecule.
    J Exp Med. 1989 Mar 1;169(3):995-1009 PMID: 2466941
  28. CD2-mediated adhesion facilitates T lymphocyte antigen recognition function.
    Nature. 1989 May 25;339(6222):312-4 PMID: 2566919
  29. Stereospecific nuclear magnetic resonance assignments of the methyl groups of valine and leucine in the DNA-binding domain of the 434 repressor by biosynthetically directed fractional 13C labeling.
    Biochemistry. 1989 Sep 19;28(19):7510-6 PMID: 2692701
  30. Role of interaction of CD2 molecules with lymphocyte function-associated antigen 3 in T-cell recognition of nominal antigen.
    Proc Natl Acad Sci U S A. 1990 Apr;87(7):2603-7 PMID: 1690889
  31. Association of CD2 and CD45 on human T lymphocytes.
    Nature. 1990 May 3;345(6270):71-4 PMID: 1970422
  32. Structure, expression, and genetic linkage of the mouse BCM1 (OX45 or Blast-1) antigen. Evidence for genetic duplication giving rise to the BCM1 region on mouse chromosome 1 and the CD2/LFA3 region on mouse chromosome 3.
    J Exp Med. 1990 Jun 1;171(6):2115-30 PMID: 1693656
  33. A soluble, single-chain T-cell receptor fragment endowed with antigen-combining properties.
    Proc Natl Acad Sci U S A. 1991 Oct 1;88(19):8646-50 PMID: 1924326
  34. Improved efficiency of protein structure calculations from NMR data using the program DIANA with redundant dihedral angle constraints.
    J Biomol NMR. 1991 Nov;1(4):447-56 PMID: 1841711
  35. Structural and functional epitopes of the human adhesion receptor CD58 (LFA-3).
    Eur J Immunol. 1992 Nov;22(11):2809-17 PMID: 1385151
  36. Crystal structure at 2.8 A resolution of a soluble form of the cell adhesion molecule CD2.
    Nature. 1992 Nov 19;360(6401):232-9 PMID: 1279440
  37. Amino acid type determination in the sequential assignment procedure of uniformly 13C/15N-enriched proteins.
    J Biomol NMR. 1993 Mar;3(2):185-204 PMID: 8477186
  38. A soluble multimeric recombinant CD2 protein identifies CD48 as a low affinity ligand for human CD2: divergence of CD2 ligands during the evolution of humans and mice.
    J Exp Med. 1993 May 1;177(5):1439-50 PMID: 7683037
  39. Mutational analysis of the CD2/CD58 interaction: the binding site for CD58 lies on one face of the first domain of human CD2.
    J Exp Med. 1993 Aug 1;178(2):549-58 PMID: 7688025
  40. Affinity and kinetic analysis of the interaction of the cell adhesion molecules rat CD2 and CD48.
    EMBO J. 1993 Dec 15;12(13):4945-54 PMID: 7903240
  41. Crystal structure of the extracellular region of the human cell adhesion molecule CD2 at 2.5 A resolution.
    Structure. 1994 Aug 15;2(8):755-66 PMID: 7994575
  42. Amino acid residues required for binding of lymphocyte function-associated antigen 3 (CD58) to its counter-receptor CD2.
    J Exp Med. 1995 Jan 1;181(1):429-34 PMID: 7528777
  43. Long-term survival of cardiac allografts in rats treated before and after surgery with monoclonal antibody to CD2.
    Transplantation. 1995 Jan 15;59(1):85-90 PMID: 7839434
  44. Conformation and function of the N-linked glycan in the adhesion domain of human CD2.
    Science. 1995 Sep 1;269(5228):1273-8 PMID: 7544493
  45. Short course single agent therapy with an LFA-3-IgG1 fusion protein prolongs primate cardiac allograft survival.
    Transplantation. 1996 Feb 15;61(3):356-63 PMID: 8610340
  46. NMR analysis of interacting soluble forms of the cell-cell recognition molecules CD2 and CD48.
    Biochemistry. 1996 May 14;35(19):5982-91 PMID: 8634239
  47. Molecular interaction between CD58 and CD2 counter-receptors mediates the ability of monocytes to augment T cell activation by IL-12.
    J Immunol. 1996 Sep 1;157(5):1886-93 PMID: 8757306
  48. T cell activation pathways: B7, LFA-3, and ICAM-1 shape unique T cell profiles.
    Crit Rev Immunol. 1995;15(3-4):235-53 PMID: 8834450
  49. Prolonged allograft survival by the inhibition of costimulatory CD2 signals but not by modulation of CD48 (CD2 ligand) in the rat.
    Transpl Int. 1996;9 Suppl 1:S323-7 PMID: 8959856
  50. AQUA and PROCHECK-NMR: programs for checking the quality of protein structures solved by NMR.
    J Biomol NMR. 1996 Dec;8(4):477-86 PMID: 9008363
  51. Identification of critical residues in the colicin E9 DNase binding region of the Im9 protein.
    Biochem J. 1997 May 1;323 ( Pt 3):823-31 PMID: 9169618
  52. Disrupting the hydrophobic patches at the antibody variable/constant domain interface: improved in vivo folding and physical characterization of an engineered scFv fragment.
    Protein Eng. 1997 Apr;10(4):435-44 PMID: 9194169
  53. Anti-CD2 receptor and anti-CD2 ligand (CD48) antibodies synergize to prolong allograft survival.
    J Exp Med. 1994 Jan 1;179(1):341-6 PMID: 7903681
Article Info
Journal
The EMBO journal
Abbr.
EMBO J
ISSN
0261-4189
Published
1999-06-01
Pages
2941-9
Language
English
Region
England
NLM ID
8208664
PMCID
PMC1171376
Subset
IM
Grants
NIAID NIH HHS · AI21226 · United States
NIAID NIH HHS · AI37581 · United States
Databases
PDB
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]